Legal Cannabis and CBD Products Sales Continue to Grow

Monday, February 5, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+ News Commentary

NEW YORK, February 5, 2018 /PRNewswire/ --

According to a report

by Ameri Research Inc., the global legal cannabis market was valued at $14.3 billion in 2016 and is forecast to grow at a CAGR of 21.1% between 2017 to 2024 or culminating to $63.5 billion by
2024. The report indicates that the factors driving the market growth include the wave of legalization, increasing usage for medical purposes, high tax revenues, and rising investment in R&D. Both the recreational and medical uses are witnessing strong demand. In the U.S, there are 28 states which have approved the use of cannabis for medical purposes, and more number of states are expected to follow over the next few years. California, the most populous state, has approved sales of cannabis products for recreational use, and sales have officially begun on January 1st., Inc. (OTC: CIIX), PotNetwork Inc. (OTC: POTN), Freedom Leaf, Inc. (OTC: FRLF), CV Sciences, Inc. (OTC: CVSI), Medical Marijuana, Inc. (OTC: MJNA)

A major segment of the legal cannabis industry is the hemp CBD market. Data published by Vote Hemp and the Hemp Business Journal estimates that total retail value of hemp products sold in the U.S. in 2016 reached $688. Sean Murphy, the Founder and Publisher of Hemp Business Journal, said: "We estimate the hemp industry will grow to $1.8 billion in sales by 2020, led by hemp food, body care, and CBD-based products. The data demonstrates the hemp industry is growing quickly at 22% five-year CAGR and being led by food and body care products, with Hemp CBD products showing a 53% AGR.", Inc. (OTCQB: CIIX) just announced breaking news this morning that, "its wholly owned foreign enterprise CBD Biotechnology Co. Ltd. ("CBD Biotech") will launch 4 new hemp infused skin care products and a cutting edge magnetic mask for the China Market in February 2018. The products have been approved for sale in China by the China Food and Drug Administration ("CFDA"). In November 2017, CBD Biotech launched its successful CBD Magic Hemp Series, an affordable hemp-infused skincare line which gained huge recognition thanks to online beauty influencer, The Godfather of Beauty.  

CBD Biotech follows this successful product introduction with the launch of the new "Live Oxygen" series, a luxury skincare line that uses nanotechnology to penetrate the skin more effectively and is designed to maximize anti-aging effects and to restore the skin's youthful glow. These products are designed to be safe for all skin types. The line includes:

The CBD Bio Tech Live Oxygen Cleanser, a gentle daily cleanser;

The CBD Bio Tech Live Oxygen Toner that hydrates the skin and balances oil, while minimizing pores;

The CBD Bio Tech Live Oxygen Facial Lotion, a light daily moisturizer; and

The CBD Bio Tech Live Oxygen Cream that provides a protective layer over the skin

In addition to the luxury Live Oxygen Series, CBD Biotech is launching the CBD BIO TECH Magnetic Mask, a leading-edge mask that utilizes magnet technology to create a low-grade electromagnetic current, which may help to rejuvenate when combined with its own blend of soothing, hydrating anti-inflammatory ingredients. Summer Yun, CEO of CBD Biotechnology Co., Ltd., comments, "The growing Chinese middle-class has shown a desire for luxury skincare products. CBD Biotech is meeting market demands by offering cutting-edge products that use the latest skincare technologies and include our exclusive hemp infused formulas.

"CBD Biotech is establishing itself as a leader in the new hemp-infused skincare market in China and intends to grow its market share in the industry by continuing to expand its product lines, developing new, innovative products for target markets, and growing its online following through well-known, Chinese beauty influencers."

PotNetwork Inc. (OTC: POTN) brings to market, a counter-culture, cutting-edge digital magazine, publishing up-to-date news and articles on the cannabis industry. Recently, the company announced that Diamond CBD will be exhibiting at "TPE 2018," a leading event intended to enable enthusiasts and entrepreneurs to interact widely with industry counterparts and experts. Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD's team consists of hemp industry pioneers and natural product experts, chemists, doctors and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils, tinctures, edibles, and vape liquids found anywhere.

Freedom Leaf, Inc. (OTCQB: FRLF) is a leading, go-to resource in the cannabis, medical and recreational marijuana, CBD and industrial hemp industries. It is involved in mergers and acquisitions in these industries, including acceleration and spin offs of new companies involved in those industries. On January 9, 2018, the company reported that it has fully acquired 100% of Green Market Europe S.L. (GME), a Spanish producer of hemp products. Since the announcement of the acquisition, June 28th 2017, Freedom Leaf Inc. Officers have been diligently working to finalize the international acquisition, and as of today all relevant documentation has been submitted, signed, and finalized. Green Market Europe S.L. facilities include a 21,000 sq. ft. light deprivation greenhouse, a 43,000 sq. ft. indoor growing research facility, and over 200 acres of outdoor production space. The light deprivation allows the increase of the number of yearly crops from 3 to 4 crops a year, and the 43,000 sq. ft. indoor grow facility is used for genetic research and cultivating additional hemp crops.

CV Sciences, Inc. (OTCQB: CVSI) operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and a consumer product division in manufacturing, marketing and selling plant-based CBD products to a range of market sectors. On January 24, 2018, the company announced that it will be exhibiting its industry-dominating brand of hemp-derived CBD oil finished products, PlusCBD Oil™, at the 2018 Integrative Health Symposium, held on February 22-24, 2018 at the New York Hilton Midtown, NY in New York, New York.  This will be the Company's second year exhibiting at this cutting-edge integrative practitioner conference. CV Sciences invites attendees to visit Booth 1011 to learn more about their botanical-based CBD product line. The Company will additionally feature its brand of practitioner-exclusive products available only to healthcare providers nationwide. Also, CV Sciences will be offering exclusive trade show discounts and show specials to practitioners attending the show.

Medical Marijuana, Inc. (OTC: MJNA) is the first-ever publicly traded cannabis company in the United States. Recently, the company announced that it has been named one of three top hemp producers of 2018 by MMJ Reporter. Medical Marijuana, Inc. has become one of the most respected and recognized leaders in the CBD hemp oil market because of its flagship product Real Scientific Hemp Oil™ (RSHO™), which is now being subsidized by the Brazilian government and exported into several other Latin American countries such as Mexico and even as a medicine in Paraguay. In 2017, the Company experienced year-over-year growth of more than 300% compared to 2016. In 2018, Medical Marijuana, Inc. will be excited to announce many new CBD hemp oil products under its subsidiaries Kannaway®, HempMeds® and Phyto Animal Health and help promote access to CBD hemp oil across the globe.

Subscribe Now! Watch us report from LIVE

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For Inc. financial news dissemination and PR services, expects to be compensated three thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. has signed a two year agreement with Inc. for one hundred thousand restricted common shares for continued financial news dissemination and PR services. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: .

For further information: Media Contact: +1-877-601-1879



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store